A team at the US National Institute of Child Health and Human Development has announced that it will be putting a contraception gel it has developed into trials starting this April. The trials will involve more than 400 couples ...
Drug giants GlaxoSmithKline and Novartis are being taken to court by Australia's consumer watchdog over "false or misleading" claims in the marketing of pain relief products, it was announced Wednesday.
Dec 6, 2017
0
0
In mammals, including humans, the cells that contract the heart muscle and enable it to beat do not regenerate after injury. After a heart attack, there is a dramatic loss of these heart muscle cells and those that survive ...
Nov 29, 2017
0
1889
More than 15 million root canals are done each year, according to the American Association of Endodontists. During the procedure, the tooth's pulp and nerve are removed before the tooth is cleaned and sealed. If bacteria, ...
Oct 23, 2017
0
0
Strong molecular bonds between antibodies and biological gels, like mucus, aren't necessary to catch pathogens as was previously thought, according to new research from the University of North Carolina at Chapel Hill. In ...
Sep 7, 2017
0
0
Some kinds of vaginal bacteria may interfere with a gel meant to curb the risk of contracting HIV, which infects more than one million women worldwide each year, researchers said Thursday.
Jun 1, 2017
0
23
Hotheaded, impulsive men who shoot first and ask questions later are a staple of Westerns and 1970s cop films, but new research shows there might be truth to the trope.
Apr 28, 2017
4
1617
An innovative "Smart Scar-Care" pad which serves the dual functions of reinforcing pressure and occlusion has been designed by The Hong Kong Polytechnic University (PolyU) to treat hypertrophic scars from burns, surgeries ...
Apr 26, 2017
0
0
(HealthDay)—For breast cancer survivors who are premenopausal at diagnosis, a pH-balanced vaginal gel is no better than placebo for improving dyspareunia and overall sexual function, according to a study published in the ...
Apr 9, 2017
0
1
A new study led by Rutgers clinician and researcher Mark Einstein is examining a revolutionary way to block transmission of human papillomavirus (HPV), the organism that causes 99 percent of cervical cancers, using a topical ...
Apr 6, 2017
0
6
